Inventor
CAPON DANIEL J
US49 patents
⚠️ This page may combine multiple inventors who share the name “CAPON DANIEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
22 patentsUS5714147AFeb 3, 1998
Hybrid immunoglobulins
GENENTECH INC309 citations99
US5514582AMay 7, 1996
Recombinant DNA encoding hybrid immunoglobulins
GENENTECH INC339 citations99
US5455165AOct 3, 1995
Expression vector encoding hybrid immunoglobulins
GENENTECH INC248 citations99
US5428130AJun 27, 1995
Hybrid immunoglobulins
GENENTECH INC861 citations99
US5225538AJul 6, 1993
Lymphocyte homing receptor/immunoglobulin fusion proteins
GENENTECH INC592 citations99
US5116964AMay 26, 1992
Hybrid immunoglobulins
GENENTECH INC1,442 citations99
US4965199AOct 23, 1990
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
GENENTECH INC624 citations99
US6406697B1Jun 18, 2002
Hybrid immunoglobulins
GENENTECH INC135 citations98
US6117655ASep 12, 2000
Nucleic acid encoding adhesion variants
GENENTECH INC96 citations98
US5565335AOct 15, 1996
Adhesion variants
GENENTECH INC153 citations98
US5336603AAug 9, 1994
CD4 adheson variants
GENENTECH INC531 citations98
US5668108ASep 16, 1997
Preparation of functional human factor VIII and pharmaceutical treatment therewith
GENENTECH INC35 citations96
US5633150AMay 27, 1997
Preparation of functional human factor VIII
GENENTECH INC46 citations96
US5618788AApr 8, 1997
Preparation of functional human factor VIII and pharmaceutical treatment therewith
GENENTECH INC42 citations96
US5618789AApr 8, 1997
Functional human factor VIII
GENENTECH INC27 citations96
US5831023ANov 3, 1998
Recombinant animal interferon polypeptides
GENENTECH INC29 citations93
US6710169B2Mar 23, 2004
Adheson variants
GENENTECH INC31 citations92
US5853978ADec 29, 1998
Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
GENENTECH INC18 citations92
US5683905ANov 4, 1997
Vectors and cell lines capable of correctly splicing exon regions
GENENTECH INC17 citations82
US6534285B1Mar 18, 2003
Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
GENENTECH INC11 citations74
US5827694AOct 27, 1998
DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
GENENTECH INC12 citations74
US6432677B1Aug 13, 2002
Non-human animal interferons
GENENTECH INC1 citations52
CELL GENESYS INC
9 patentsUS6319494B1Nov 20, 2001
Chimeric chains for receptor-associated signal transduction pathways
CELL GENESYS INC348 citations97
US6103521AAug 15, 2000
Multispecific chimeric receptors
CELL GENESYS INC209 citations97
US5359046AOct 25, 1994
Chimeric chains for receptor-associated signal transduction pathways
CELL GENESYS INC729 citations97
US6514752B1Feb 4, 2003
Homologous recombination for universal donor cells and chimeric mammalian hosts
CELL GENESYS INC60 citations94
US6407221B1Jun 18, 2002
Chimeric chains for receptor-associated signal transduction pathways
CELL GENESYS INC65 citations94
US6139835AOct 31, 2000
Homologous recombination for allogeneic donor cells
CELL GENESYS INC54 citations94
US5837544ANov 17, 1998
Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
CELL GENESYS INC43 citations94
US5741899AApr 21, 1998
Chimeric receptors comprising janus kinase for regulating cellular pro liferation
CELL GENESYS INC80 citations94
US6077947AJun 20, 2000
DNA encoding an intracellular chimeric receptor comprising Janus kinase
CELL GENESYS INC35 citations91
ABGENIX INC
6 patentsUS6673986B1Jan 6, 2004
Generation of xenogeneic antibodies
ABGENIX INC478 citations99
US6657103B1Dec 2, 2003
Human antibodies derived from immunized xenomice
ABGENIX INC260 citations99
US6162963ADec 19, 2000
Generation of Xenogenetic antibodies
ABGENIX INC1,334 citations99
US6150584ANov 21, 2000
Human antibodies derived from immunized xenomice
ABGENIX INC3,069 citations99
US6075181AJun 13, 2000
Human antibodies derived from immunized xenomice
ABGENIX INC3,137 citations99
US6114598ASep 5, 2000
Generation of xenogeneic antibodies
ABGENIX INC1,486 citations97
BIOMOLECULAR HOLDINGS LLC
4 patentsUS12509502B2Dec 30, 2025
Hybrid immunoglobulin containing nonpeptidyl linkage
BIOMOLECULAR HOLDINGS LLC0 citations61
US12371480B2Jul 29, 2025
Peptide-hinge-free flexible antibody-like molecule
BIOMOLECULAR HOLDINGS LLC0 citations61
US11066459B2Jul 20, 2021
Hybrid immunoglobulin containing non-peptidyl linkage
BIOMOLECULAR HOLDINGS LLC1 citations61
US12473363B2Nov 18, 2025
NK/monocyte engagers
BIOMOLECULAR HOLDINGS LLC0 citations51
CAPON DANIEL J
3 patentsUS9725503B2Aug 8, 2017
Peptide-hinge-free flexible antibody-like molecule
CAPON DANIEL J8 citations83
US11345745B2May 31, 2022
Peptide-hinge-free flexible antibody-like molecule
CAPON DANIEL J2 citations72
US10968263B2Apr 6, 2021
Affinity support and method for trapping substance using the same
CAPON DANIEL J2 citations72
VIROLOGIC INC
2 patentsUS6242187B1Jun 5, 2001
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
VIROLOGIC INC83 citations97
US6942969B2Sep 13, 2005
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
VIROLOGIC INC7 citations73